AVA360 Advertising

The potential of convalescent plasma therapy for COVID-19 patients

With researchers around the world racing to develop a vaccine for COVID-19, attention is increasingly turning to a potential stop-gap measure – convalescent plasma. The yellowish gold part of our blood that contains antibodies to help fight viruses is the focus of research in labs and hospitals and shows early signs of promise. John Yang reports.

Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6

Follow us:
Facebook: http://www.pbs.org/newshour
Twitter: http://www.twitter.com/newshour
Instagram: http://www.instagram.com/newshour
Snapchat: @pbsnews

PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe
U.S. & Canada
Sign in or sign up to post comments.
Be the first to comment